Enveric Biosciences Inc (ENVB)
0.8153
-0.01
(-0.74%)
USD |
NASDAQ |
May 21, 16:00
0.80
-0.02
(-1.88%)
After-Hours: 20:00
Enveric Biosciences Free Cash Flow (Quarterly): -2.598M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.598M |
| December 31, 2023 | -1.751M |
| September 30, 2023 | -2.740M |
| June 30, 2023 | -4.466M |
| March 31, 2023 | -5.142M |
| December 31, 2022 | -3.468M |
| September 30, 2022 | -4.569M |
| June 30, 2022 | -4.639M |
| March 31, 2022 | -5.054M |
| December 31, 2021 | -4.257M |
| September 30, 2021 | -2.206M |
| June 30, 2021 | -2.022M |
| March 31, 2021 | -3.837M |
| December 31, 2020 | -2.294M |
| September 30, 2020 | -0.3937M |
| June 30, 2020 | 1.091M |
| March 31, 2020 | -2.336M |
| December 31, 2019 | -1.036M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.5058M |
| March 31, 2019 | -0.9961M |
| December 31, 2018 | -0.9914M |
| September 30, 2018 | -1.281M |
| June 30, 2018 | 0.1663M |
| March 31, 2018 | -0.4596M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.9383M |
| September 30, 2017 | -0.0986M |
| June 30, 2017 | -0.8604M |
| March 31, 2017 | -0.8484M |
| December 31, 2016 | 0.2645M |
| September 30, 2016 | -2.701M |
| June 30, 2016 | -0.3181M |
| March 31, 2016 | 0.0216M |
| September 30, 2015 | -8.861M |
| June 30, 2015 | -2.062M |
| March 31, 2015 | -0.0012M |
| December 31, 2014 | -0.004M |
| September 30, 2014 | 0.0013M |
| June 30, 2014 | -0.0127M |
| March 31, 2014 | -0.0278M |
| December 31, 2013 | -0.0004M |
| September 30, 2013 | -0.0052M |
| June 30, 2013 | -0.0037M |
| March 31, 2013 | -0.0122M |
| December 31, 2012 | -0.0038M |
| September 30, 2012 | -0.0051M |
| June 30, 2012 | -0.0039M |
| March 31, 2012 | -0.0121M |
| December 31, 2011 | -0.0048M |
| September 30, 2011 | -0.0037M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.142M
Minimum
Mar 2023
1.091M
Maximum
Jun 2020
-2.611M
Average
-2.467M
Median
Free Cash Flow (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | 0.793M |
| Seelos Therapeutics Inc | -4.642M |
| Cardiff Oncology Inc | -7.82M |
| BioVie Inc | -5.852M |
| Adial Pharmaceuticals Inc | -1.626M |